1. Market Research
  2. > Pathology Industry

Leukemia Industry, August 2015 Market Reports from Top Publishers

You might be interested in: Diagnostics, in Vitro Diagnostic Reagent, Drug, Molecular Diagnostic, Flow Cytometry, Clinical Trial, Pap Smear, Biomarker, Blood Supply, Antibody, Cancer Diagnostic, Pharmaceutical.


 
1-10 of about 200 reports for Leukemia

Purchase Reports From Reputable Market Research Publishers

Leukemia Treatment Drugs Markets in China

Leukemia Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • July 2015
  • by Asia Market Information & Development Company

China's demand for Leukemia Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed ...

Global Acute and Chronic Myelogenous Leukemia Partnering 2010-2015

Global Acute and Chronic Myelogenous Leukemia Partnering 2010-2015

  • $ 1 495
  • Industry report
  • July 2015
  • by Currentpartnering

The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service. The Acute and Chronic ...

Global Leukemia Partnering 2010-2015

Global Leukemia Partnering 2010-2015

  • $ 1 495
  • Industry report
  • July 2015
  • by Currentpartnering

The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service. The Leukemia Partnering ...

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an ...

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview ...

Refractory Leukemia - Pipeline Review, H1 2015

Refractory Leukemia - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • June 2015
  • by Global Markets Direct

Refractory Leukemia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Refractory Leukemia - Pipeline Review, H1 2015’, provides an overview of the Refractory Leukemia’s therapeutic pipeline. ...

Leukemia Drug Pipeline Update 2015

Leukemia Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Leukemia includes a broad variety of histological separate disorders which make the leukemia market segmented. There are today 404 companies plus partners developing 533 leukemia drugs in 864 developmental ...

The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2015
  • by Global Data

Summary The Leukemia & Lymphoma Society, Inc. (LLS) is a healthcare organization. The organization provides funding to blood cancer research, and offers education and patient services. It provides services, ...

Hairy Cell Leukemia - Pipeline Review, H1 2015

Hairy Cell Leukemia - Pipeline Review, H1 2015

  • $ 2 000
  • Company report
  • May 2015
  • by Global Markets Direct

Hairy Cell Leukemia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Hairy Cell Leukemia - Pipeline Review, H1 2015’, provides an overview of the Hairy Cell Leukemia’s therapeutic ...

 Acute Promyelocytic Leukemia-Pipeline Insights, 2015

Acute Promyelocytic Leukemia-Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Acute Promyelocytic Leukemia- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Acute Promyelocytic Leukemia. The main objective of this ...

About 4 600 reports for Leukemia

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2015
    77 pages
  • Cancer  

    Leukemia  

    Cell Therapy  

  • United States  

View report >

Pathology Description

January 2015

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.